Evidence map›Paper›PMID 35498435›Full record

ReviewFrontiers in endocrinology2022

Rehabilitation of Individuals With Diabetes Mellitus: Focus on Diabetic Myopathy.

Daniela Bassi-Dibai, Aldair Darlan Santos-de-Araújo, Almir Vieira Dibai-Filho, Lisiane Fernanda Simeão de Azevedo, Cássia da Luz Goulart, Gabriela Costa Pontes Luz, Patrick Rademaker Burke, Adriana Sanches Garcia-Araújo, Audrey Borghi-Silva

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in endocrinology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it, 21 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Review
  16. Article
  17. To do one and to get more: Part I. Diabetes and bone.Journal of the Chinese Medical Association : JCMA · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Daniela Bassi-DibaiPostgraduate Program in Environment, Universidade Ceuma, São Luís, Brazil.
Aldair Darlan Santos-de-AraújoPostgraduate Program in Physical Therapy, Universidade Federal de São Carlos, São Carlos, Brazil.
Almir Vieira Dibai-FilhoPostgraduate Program in Adult Health, Universidade Federal do Maranhão, São Luís, Brazil.
Lisiane Fernanda Simeão de AzevedoPostgraduate Program in Environment, Universidade Ceuma, São Luís, Brazil.
Cássia da Luz GoulartPostgraduate Program in Physical Therapy, Universidade Federal de São Carlos, São Carlos, Brazil.
Gabriela Costa Pontes LuzDepartment of Physical Therapy, Universidade Ceuma, São Luís, Brazil.
Patrick Rademaker BurkeDepartment of Medicine, Universidade Federal do Maranhão, Pinheiro, Brazil.
Adriana Sanches Garcia-AraújoDepartment of Physical Therapy, Universidade Federal de São Carlos, São Carlos, Brazil.
Audrey Borghi-SilvaPostgraduate Program in Physical Therapy, Universidade Federal de São Carlos, São Carlos, Brazil.
Universidade Federal de São Carlos · BRCentro Universitário do Maranhão · BRUniversidade Federal do Maranhão · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Diabetes mellitus (DM) is a chronic metabolic disease characterized by high blood glucose levels, causing serious damage to the cardiovascular, respiratory, renal and other systems. The prevalence of type 2 diabetes mellitus (T2DM) was 6.28% in 2017, considering all age groups worldwide (prevalence rate of 6,059 cases per 100,000), and its global prevalence is projected to increase to 7,079 cases per 100,000 by 2030. Furthermore, these individuals are often affected by diabetic myopathy, which is the failure to preserve muscle mass and function in the course of DM. This happens in type 1 diabetes mellitus (T1DM) and T2DM. As skeletal muscle plays a key role in locomotion and glucose homeostasis, diabetic myopathy may contribute to additional complications of the disease. In addition, chronic hyperglycemia is associated with lung functional changes seen in patients with DM, such as reduced lung volumes and compliance, inspiratory muscle strength, and lung elastic recoil. Thus, the weakness of the inspiratory muscles, a consequence of diabetic myopathy, can influence exercise tolerance. Thus, moderate strength training in T2DM can contribute to the gain of peripheral muscle strength. Although the literature is robust on the loss of mass and consequent muscle weakness in diabetic myopathy, triggering pathophysiological factors, the impact on functional capacity, as well as the prescription of physical exercise for this condition deserves to be further explored. This review aims to explore the consequences of diabetic myopathy and its implication in rehabilitation from prescription to safety in the practice of physical exercises for these individuals.

Indexed as

Diabetes Mellitus, Type 1Diabetes Mellitus, Type 2Muscular DiseasesExercise ToleranceHumansMuscle Strengthcardiometabolic rehabilitationdiabetes mellitusdiabetic myopathymuscular strengthphysical exercise

Identifiers

PMID35498435
PMCPMC9047902
OpenAlexW4223976223

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.